Terms: = Kidney tumors AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671
1210 results:
1. Management of Nontraumatic Spontaneous Renal Hemorrhage (Wünderlich Syndrome) through Robotic-Assisted Laparoscopic Nephrectomy: A Case Series.
Tao B; Zhang H; Zhang G; Liu H; Meng L; Zhu X; Ji X; Jia G; Qi A; Wang C
Am J Case Rep; 2024 Apr; 25():e942826. PubMed ID: 38659203
[TBL] [Abstract] [Full Text] [Related]
2. Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002-2021.
Johansson ALV; Kønig SM; Larønningen S; Engholm G; Kroman N; Seppä K; Malila N; Steig BÁ; Gudmundsdóttir EM; Ólafsdóttir EJ; Lundberg FE; Andersson TM; Lambert PC; Lambe M; Pettersson D; Aagnes B; Friis S; Storm H
Acta Oncol; 2024 Apr; 63():179-191. PubMed ID: 38597666
[TBL] [Abstract] [Full Text] [Related]
3. Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma.
Luomala L; Mattila K; Vainio P; Nisén H; Pellinen T; Lohi J; Laajala TD; Järvinen P; Koskenniemi AR; Jaakkola P; Mirtti T
Cancer Med; 2024 Feb; 13(3):e6998. PubMed ID: 38400673
[TBL] [Abstract] [Full Text] [Related]
4. Natural history of bone-only metastasis in renal cell carcinoma.
Tang B; Duan R; Fan Z; Yan X; Li S; Zhou L; Li J; Xu H; Mao L; Lian B; Wang X; Bai X; Wei X; Li C; Cui C; Si L; Chi Z; Guo J; Sheng X
Urol Oncol; 2024 Apr; 42(4):119.e17-119.e22. PubMed ID: 38383241
[TBL] [Abstract] [Full Text] [Related]
5. Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study.
Kataoka S; Nishikawa Y; Funakoshi T; Horimatsu T; Sakuragi M; Uchino E; Hiragi S; Yamamoto S; Sakai K; Matsubara T; Yanagita M; Muto M
Int J Clin Oncol; 2024 Apr; 29(4):398-406. PubMed ID: 38351273
[TBL] [Abstract] [Full Text] [Related]
6. Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2.
Lovvorn HN; Renfro LA; Benedetti DJ; Kotagal M; Phelps HM; Ehrlich PF; Lo AC; Sandberg JK; Treece AL; Gow KW; Glick RD; Davidoff AM; Cost NG; Dix DB; Fernandez CV; Dome JS; Geller JI; Mullen EA
J Am Coll Surg; 2024 Apr; 238(4):733-749. PubMed ID: 38251681
[TBL] [Abstract] [Full Text] [Related]
7. Surgical management of Rathke cleft cysts in pediatric patients: a single institution experience.
Brandel MG; Lin C; Rennert RC; Plonsker JH; Khan UA; Crawford JR; Nation J; Levy ML
Childs Nerv Syst; 2024 May; 40(5):1367-1375. PubMed ID: 38240786
[TBL] [Abstract] [Full Text] [Related]
8. Characteristics and Clinical Outcomes of Children With Wilms' Tumour: A 15-year Experience in a Single Centre in Nigeria.
Nasir AA; Abdur-Raheem NT; Abdur-Rahman LO; Ibiyeye TT; Sayomi TO; Adedoyin OT; Adeniran JO
J Pediatr Surg; 2024 May; 59(5):1009-1014. PubMed ID: 38184433
[TBL] [Abstract] [Full Text] [Related]
9. Association between circadian physical activity patterns and cancer incidence through regulation of inflammation: A UK biobank study.
Bai P; Ning X; Gao R; Shao X; Zhou S; Li J; Lin Y; Liu H; Zhang M; Yu P
Prev Med; 2024 Feb; 179():107831. PubMed ID: 38145876
[TBL] [Abstract] [Full Text] [Related]
10. Incidence and outcomes of fever of unknown origin after kidney transplant in the modern era.
Jorgenson MR; Parajuli S; Kleiboeker HL; Felix DC; Astor BC; Saddler CM; Smith JA; Mandelbrot DA
Clin Transplant; 2024 Jan; 38(1):e15217. PubMed ID: 38078682
[TBL] [Abstract] [Full Text] [Related]
11. Assessment of Ki-67 proliferation index in prognosis prediction in patients with nonmetastatic clear cell renal cell carcinoma and tumor thrombus.
Zhao J; Ding X; Peng C; Tian X; Wang M; Fu Y; Guo H; Bai X; Zhai X; Huang Q; Liu K; Li L; Ye H; Zhang X; Ma X; Wang H
Urol Oncol; 2024 Jan; 42(1):23.e5-23.e13. PubMed ID: 38030468
[TBL] [Abstract] [Full Text] [Related]
12. Predicting recurrence and survival in patients with non-metastatic renal-cell carcinoma after nephrectomy: a prospective population-based study with multicenter validation.
Wang Y; Xuan Y; Su B; Gao Y; Fan Y; Huang Q; Zhang P; Gu L; Niu S; Shen D; Li X; Wang B; Zhu Q; Ouyang Z; Xie J; Ma X
Int J Surg; 2024 Feb; 110(2):820-831. PubMed ID: 38016139
[TBL] [Abstract] [Full Text] [Related]
13. Safety of laparoscopic liver resection for high-risk patients.
Maeda T; Otsuka Y; Okada R; Ito Y; Matsumoto Y; Kimura K; Ishii J; Tsuchiya M; Kaneko H; Funahashi K
J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1283-1292. PubMed ID: 37822140
[TBL] [Abstract] [Full Text] [Related]
14. Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study.
Jiang R; Wang X; Li Z; Cai H; Sun Z; Wu S; Chen S; Hu H
BMC Urol; 2023 Sep; 23(1):150. PubMed ID: 37736725
[TBL] [Abstract] [Full Text] [Related]
15. Risk factors of worsening kidney function and mortality in patients with renal vein thrombosis: a retrospective study.
Wanaratwichit P; Chai-Adisaksopha C; Inmutto N; Noppakun K
J Nephrol; 2024 Jan; 37(1):131-140. PubMed ID: 37702914
[TBL] [Abstract] [Full Text] [Related]
16. Robotic partial nephrectomy for renal tumor: The pentafecta outcomes of a single surgeon experience.
Wang BR; Ou YC; Huang LH; Lu CH; Weng WC; Yang CK; Hsu CY; Lin YS; Chang YK; Tung MC
Asian J Surg; 2023 Sep; 46(9):3587-3592. PubMed ID: 37670437
[TBL] [Abstract] [Full Text] [Related]
17. The efficacy of the new Bosniak classification v.2019 in benign lesions prediction within the higher Bosniak cysts classes.
Elbaset MA; Ashour R; Elgamal M; Elbatta A; Ghobrial FK; Abouelkheir RT; Mosbah A; Osman Y
Urol Oncol; 2023 Oct; 41(10):434.e1-434.e7. PubMed ID: 37574368
[TBL] [Abstract] [Full Text] [Related]
18. The Association of kidney Function and Inflammatory Biomarkers with Epithelial Ovarian Cancer Risk.
Hathaway CA; Townsend MK; Sklar EM; Thomas-Purcell KB; Terry KL; Trabert B; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1451-1457. PubMed ID: 37540498
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value and model construction of preoperative inflammatory markers in patients with metastatic renal cell carcinoma.
Wang J; Ye J; Zhao X; Li X; Ma X
World J Surg Oncol; 2023 Jul; 21(1):211. PubMed ID: 37480143
[TBL] [Abstract] [Full Text] [Related]
20. Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Bibliometric Analysis via CiteSpace from 2000 to 2022.
Xu J; Huang Z; Gao S; Deng G; Di J
Urol Int; 2023; 107(8):755-771. PubMed ID: 37454653
[TBL] [Abstract] [Full Text] [Related]
[Next]
